GILD vs OLN · P/E 18, rev $29.44B vs rev $6.54B
Gilead Sciences Inc (GILD) versus Olin Corporation (OLN) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. OLN currently screens at market cap $2.62B.
Not investment advice. Open the GILD and OLN stock pages for the full models.
Not investment advice.